What is QGEN's five-year median P/S?

There are not enough weekly readings yet for a five-year median P/S.

Does a low historical rank mean a stock is a buy?

No. The rank compares QGEN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

QIAGEN NV (QGEN) P/S ratio history

Health Care

$50.33

Latest weekly close · Market cap $10.4B

QIAGEN's P/S of 4.9x does not have enough weekly history to rank yet (as of Oct 29, 2026).

Forward P/E 19.3× (analyst estimates, not ranked).

No P/S chart for QGEN right now

QGEN has no weekly P/S history to chart yet.

P/S

n/mnot ranked

P/S needs more weekly history to be ranked.

Growth, last 12 months vs the year before

Revenue: 0%
EPS: n/m

Health Care peers on P/S

Each percentile compares a stock with its own last five years.

Compare QGEN with peers

Health Care peers of QGEN on P/S
Stock	P/S	Versus its own history	5-year percentile
AAgilent Technologies	7.0×	Historically high	95
AVTRAvantor Inc	1.7×	Within its usual range	33
BIOBio-Rad Laboratories Inc	4.0×	Within its usual range	63
BRKRBruker Corp	2.7×	Within its usual range	35
CRLCharles River Laboratories	4.5×	Historically high	94

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on QGEN

No articles about QGEN yet. How valuation percentiles work

Loading peers and related research…

About this history

What is QGEN's current P/S?: QIAGEN's P/S of 4.9x does not have enough weekly history to rank yet (as of Oct 29, 2026).
What is QGEN's five-year median P/S?: There are not enough weekly readings yet for a five-year median P/S.
Does a low historical rank mean a stock is a buy?: No. The rank compares QGEN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.